International Organising Committee |
Symposium Chairmen |
| Prof. K. AUGUSTYNS (University of Antwerp, Antwerp, Belgium) |
| Dr E. DIFFERDING (Louvain-la-Neuve, Belgium) |
International Organising Committee |
| Prof. G. ECKER (University of Vienna, Vienna, Austria) |
| Dr P. ETTMAYER (Boehringer Ingelheim, Vienna, Austria) |
| Prof. Dr E. OTTOW (Bayer HealthCare, Berlin, Germany) |
| Prof. H. TIMMERMAN (VU University Amsterdam, Amsterdam, The Netherlands) |
Local Organising Committee |
Members |
| Prof. W. DEHAEN (KULeuven, Heverlee, Belgium) |
| Prof. P. HERDEWIJN (KULeuven, Leuven, Belgium) |
| Dr B. KENDA (UCB, Braine-l'Alleud, Belgium) |
| Prof. D. LAMBERT (UCL, Bruxelles, Belgium) |
| Prof. B. U. MAES (University of Antwerp, Antwerp, Belgium) |
| Prof. B. MASEREEL (UNamur, Namur, Belgium) |
| Prof. J. NEVE (ULB, Bruxelles, Belgium) |
| Prof. B. PIROTTE (ULg, Liège, Belgium) |
| Prof. J. QUETIN-LECLERCQ (CATHOLIC UNIVERSITY OF LOUVAIN (UCL), Brussels, Belgium) |
| Dr D. SURLERAUX (Idenix, Saint Gely du Fesc, France) |
| Dr P. TEN HOLTE (Johnson & Johnson PRD, Beerse, Belgium) |
| Prof. D. TOURWE (VUB, Brussels, Belgium) |
| Prof. S. VAN CALENBERGH (UGent, Ghent, Belgium) |
| Prof. J. VAN DER EYCKEN (UGent, Ghent, Belgium) |
| Dr G. VAN LOMMEN (Galapagos, Mechelen, Belgium) |
Scientific Advisory Board |
Members |
| Prof M. ABOU-GHARBIA (Temple University, Philadelphia, United States) |
| Dr D. J. ABRAHAM (Virginia Commonwealth University, Richmond, United States) |
| Prof. S. O. BACHURIN (Institute of Physiologically Active Compounds, Chernogolovka, Russia) |
| Dr D. BARRETT (Astellas, Osaka, Japan) |
| Prof K. P. BOGESO (H. Lundbeck A/S, Valby, Denmark) |
| Dr S. BOYER (AstraZeneca, Södertälje, Sweden) |
| Dr N. CARRUTHERS (Johnson & Johnson R&D, San Diego, United States) |
| Dr M. COWART (Abbott Labs, Abbott Park, IL, United States) |
| Prof G. CRISTALLI (University of Camerino, Camerino, Italy) |
| Prof N. DE SOUZA (University Institute of Chemical Technology, Mumbai, India) |
| Prof. F. DIEDERICH (ETH ZURICH, Zürich, Switzerland) |
| Dr E. DIMAURO (Amgen, Cambridge, United States) |
| Dr M. DUGGAN (Link Medicine Corporation, Cambridge, United States) |
| Dr S. EAST (Evotec, Oxfordshire, United Kingdom) |
| Dr J. FISCHER (Richter Plc, Budapest, Hungary) |
| Prof M. FRIDKIN (Weizmann Institute, Rehovot, Israel) |
| Prof. R. GANELLIN (University College London, London, United Kingdom) |
| Dr D. GREEN (GlaxoSmithKline, Stevenage, United Kingdom) |
| Dr E. HAAKSMA (Boehringer Ingelheim Austria, Wien, Austria) |
| Dr L. HENNEQUIN (AstraZeneca, Reims, France) |
| Prof. P. HERDEWIJN (KULeuven, Leuven, Belgium) |
| Prof. K. KIEC-KONONOWICZ (Jagiellonian University, Krakow, Poland) |
| Prof D. KIKELJ (University of Ljubljana, Ljubljana, Slovenia) |
| Prof. P. KROGSGAARD-LARSEN (The Carlsberg Foundation, Copenhagen, Denmark) |
| Prof C. KRUSE (Abbott, Weesp, The Netherlands) |
| Dr P. LEESON (United Kingdom) |
| Dr D. LESUISSE (Sanofi Aventis, Chilly-Mazarin, France) |
| Prof. R. LEURS (VU University Amsterdam, Amsterdam, The Netherlands) |
| Prof. M. L. LOPEZ-RODRIGUEZ (Complutense University of Madrid, Madrid, Spain) |
| Dr H. P. MAERKI (F. Hoffmann-La Roche, Basel, Switzerland) |
| Prof. B. MASEREEL (UNamur, Namur, Belgium) |
| Prof. P. MÁTYUS (Semmelweis University, Budapest, Hungary) |
| Dr L. MEERPOEL (Johnson & Johnson PRD, Beerse, Belgium) |
| Dr R. METTERNICH (Caprotec bioanalytics, Basel, Switzerland) |
| Dr M. MISSBACH (Novartis, Basel, Switzerland) |
| Prof. L. MOSTI (University of Genova, Genova, Italy) |
| Prof. C. MÜLLER (University of Bonn, Bonn, Germany) |
| Prof. K. MÜLLER (F. Hoffmann-La Roche, Basel, Switzerland) |
| Prof. J. NEVE (ULB, Bruxelles, Belgium) |
| Prof. K. NICOLAOU (The Scripps Research Institute, Houston, United States) |
| Prof. C. NOE (University of Vienna, Vienna, Austria) |
| Prof E. NOVELLINO (University of Naples, Naples, Italy) |
| Prof D. OLIVER (North-West University, Potchefstroom, South Africa) |
| Prof. Dr E. OTTOW (Bayer HealthCare, Berlin, Germany) |
| Prof. R. PELLICCIARI (University of Perugia & EFMC, Perugia, Italy) |
| Dr A. ROBICHAUD (Sage, Princeton, United States) |
| Dr Y. ROLLAND (Société de Chimie Thérapeutique, Châtenay-Malabry, France) |
| Prof. F. SANZ (University Pompeu Fabra, Barcelona, Spain) |
| Prof. G. SERRA (Udelar, Montevideo, Uruguay) |
| Dr G. STEMP (GlaxoSmithKline, Harlow, United Kingdom) |
| Prof. H. U. STILZ (Sanofi-Aventis, Malov, Denmark) |
| Prof. A. TARTAR (University Lille 2, Lille, France) |
| Dr S. VAN BOECKEL (Schering-Plough, Oss, The Netherlands) |
| Dr L. VAN HIJFTE (Janssen Cilag, Val de Reuil, France) |
| Prof. H. WALDMANN (Max Planck Institute of Molecular Physiology, Dortmund, Germany) |
| Dr E. WALLEN (University of Kuopio, Kuopio, Finland) |
| Prof. D. WINKLER (Csiro Molecular Science, Clayton South , Australia) |
| Dr A. WOOD (Pfizer, Cambridge, United States) |
| Prof. N. S. ZEFIROV (Institute of Physiologically Active Compounds, Moscow, Russia) |
| Dr L.-H. ZHANG (Beying Medical University, Beying, China) |